IL4 and rheumatoid arthritis: IL-4 treatment significantly decreased MMP-1 gene expression levels compared to the RA group, in conformity with [48] who determined the effects of Th2-type cytokines (interleukin (IL)-4 and -13) on conjunctival fibroblasts of vernal keratoconjunctivitis (VKC).